abstract |
An object of the present invention is to provide an effective hemostatic composition at a wound site. A hemostatic composition comprising, as an active ingredient, a composite material having hydroxyapatite or calcium carbonate having an average particle size of 50 μm or less in a biocompatible polymer matrix. [Selection diagram] None |